| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, …
Over the last 12 months, insiders at Context Therapeutics Inc. have bought $0 and sold $0 worth of Context Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Context Therapeutics Inc. have bought $95,796 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $70,080 was made by Lehr Martin A. (Chief Executive Officer) on 2025‑06‑09.
| 2025-06-09 | Lehr Martin A. | Chief Executive Officer | 100,000 0.1111% | $0.70 | $70,080 | +72.14% | ||
| 2025-06-06 | Minai-Azary Jennifer Lynn | Chief Financial Officer | 40,010 0.0428% | $0.64 | $25,486 | +81.45% | ||
| 2025-06-06 | Levit Alex C. | Chief Legal Officer, Corp. Sec | 20,000 0.0193% | $0.58 | $11,520 | +81.45% | ||
| 2023-02-21 | Lehr Martin A. | Chief Executive Officer | 5,823 0.0382% | $0.84 | $4,900 | +28.27% | ||
| 2023-02-13 | Lehr Martin A. | Chief Executive Officer | 5,606 0.0365% | $0.87 | $4,901 | +22.21% | ||
| 2023-02-06 | Lehr Martin A. | Chief Executive Officer | 5,040 0.032% | $0.97 | $4,900 | +6.25% | ||
| 2023-01-30 | Lehr Martin A. | Chief Executive Officer | 7,027 0.0449% | $0.70 | $4,901 | +47.88% | ||
| 2023-01-23 | Lehr Martin A. | Chief Executive Officer | 6,839 0.0434% | $0.72 | $4,901 | +42.86% | ||
| 2023-01-17 | Lehr Martin A. | Chief Executive Officer | 6,783 0.0442% | $0.74 | $4,995 | +42.66% | ||
| 2022-12-16 | Lehr Martin A. | Chief Executive Officer | 20,000 0.1253% | $0.74 | $14,796 | +26.06% | ||
| 2022-12-16 | Minai-Azary Jennifer Lynn | Chief Financial Officer | 25,000 0.1566% | $0.74 | $18,500 | +26.06% | ||
| 2022-12-09 | Levit Alex C. | Chief Legal Officer, Corp. Sec | 6,000 0.0384% | $0.85 | $5,095 | +11.23% | ||
| 2022-08-19 | Lehr Martin A. | Chief Executive Officer | 13,000 0.0824% | $1.85 | $24,064 | -42.90% | ||
| 2022-08-17 | Minai-Azary Jennifer Lynn | Chief Financial Officer | 15,000 0.0939% | $1.80 | $27,000 | -41.67% | ||
| 2022-08-16 | Sahmoud Tarek | Chief Medical Officer | 10,000 0.0636% | $1.95 | $19,500 | -45.05% | ||
| 2021-12-16 | Lehr Martin A. | Chief Executive Officer | 13,000 0.4558% | $3.22 | $41,850 | -41.36% | ||
| 2021-10-22 | Lehr Martin A. | Chief Executive Officer | 10,000 0.2524% | $5.00 | $50,000 | -71.82% | ||
| 2021-10-22 | Levit Alex C. | Chief Legal Officer, Corp. Sec | 3,000 0.0757% | $5.00 | $15,000 | -71.82% |
| Lehr Martin A. | Chief Executive Officer | 920190 1.0015% | $178,516.86 | 11 | 0 | +12.02% |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | 80010 0.0871% | $15,521.94 | 3 | 0 | +21.95% |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | 29000 0.0316% | $5,626.00 | 3 | 0 | +6.95% |
| Sahmoud Tarek | Chief Medical Officer | 10000 0.0109% | $1,940.00 | 1 | 0 | <0.0001% |
$18,815,063 | 62 | -6.45% | $13.7M | |
$1,993,425 | 46 | -21.91% | $13.95M | |
$931,435 | 28 | 16.31% | $24.8M | |
$226,127 | 22 | -27.62% | $21.96M | |
$114,619,342 | 20 | -7.41% | $16.39M |
| Increased Positions | 17 | +38.64% | 6M | +8.5% |
| Decreased Positions | 13 | -29.55% | 11M | -15.25% |
| New Positions | 9 | New | 3M | New |
| Sold Out Positions | 5 | Sold Out | 1M | Sold Out |
| Total Postitions | 48 | +9.09% | 65M | -6.75% |
| Mpm Bioimpact Llc | $22,794.00 | 15.99% | 14.71M | 0 | 0% | 2025-09-30 |
| Avidity Partners Management Lp | $13,922.00 | 9.76% | 8.98M | +2M | +20.12% | 2025-09-30 |
| Nextech Invest, Ltd. | $11,500.00 | 8.07% | 7.42M | 0 | 0% | 2025-09-30 |
| Deep Track Capital, Lp | $11,500.00 | 8.07% | 7.42M | 0 | 0% | 2025-09-30 |
| Blue Owl Capital Holdings Lp | $11,482.00 | 8.05% | 7.41M | 0 | 0% | 2025-09-30 |
| Great Point Partners I Lp | $7,260.00 | 5.09% | 4.68M | 0 | 0% | 2025-09-30 |
| Franklin Resources Inc | $6,205.00 | 4.35% | 4M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $5,417.00 | 3.8% | 3.5M | +134,449 | +4% | 2025-09-30 |
| Blackstone Inc. | $3,783.00 | 2.65% | 2.44M | 0 | 0% | 2025-09-30 |
| Alyeska Investment Group, L.P. | $2,578.00 | 1.81% | 1.66M | 0 | 0% | 2025-09-30 |